EP0087161A2 — Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
Assigned to Key Pharmaceuticals Inc · Expires 1983-08-31 · 43y expired
What this patent protects
Herpes infections are treated with a mixture comprising a major amount of isopropylmyristate and a minor amount of a 4-(lower alkyl)-2,6-(bis-tert-butyl)-phenol, with 2,6-(bis-tert-butyl)-4-hydroxy-toluene being a preferred embodiment of the 4-(lower alkyl)-2,6-(bis-tert-butyl)-p…
USPTO Abstract
Herpes infections are treated with a mixture comprising a major amount of isopropylmyristate and a minor amount of a 4-(lower alkyl)-2,6-(bis-tert-butyl)-phenol, with 2,6-(bis-tert-butyl)-4-hydroxy-toluene being a preferred embodiment of the 4-(lower alkyl)-2,6-(bis-tert-butyl)-phenol.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.